Pfizer CEO Albert Bourla raked in $24.3 million in total compensation in 2021. In other news, tinnitus (ringing or buzzing in one or both ears) might be a side effect of COVID-19 vaccines.

The inexpensive antidepressant fluvoxamine might help keep patients with Covid-19 from developing severe disease, according to a study published in The Lancet Global Health. Researchers found in another study that the coronavirus can infect cells of the inner ear, which may help explain the balance problems, hearing loss and tinnitus (ringing in the ears) experienced by some Covid-19 patients.

Otonomy shares plunged 50.1 percent at news that the company’s drug to treat Meniere’s disease failed to hit the primary endpoint in a Phase III trial.

Auris Medical AG announced that the Swiss-based company’s Phase III tinnitus trial for Keyzilen failed to meet endpoints.

A sound-emitting device worn in the ear during sleep may train the brain to ignore an annoying chronic ringing in the ears, a new study suggests.

Auris Medical Holding AG said its experimental drug for acute inner ear tinnitus missed the main goals of a late-stage study.

People with tinnitus – a ringing or other “phantom” sounds in their ears – may benefit from a treatment that sends electromagnetic pulses into the brain, suggests a new study. Transcranial magnetic simulation (TMS) is not currently available for the average person with tinnitus, but the study’s lead author hopes it will someday be used […]